跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,606 条关于
“Chiesi Pharmaceuticals”
全部
14,606
临床试验
5,749
药物
1,832
机构
2,123
资讯
4,902
5个月前
Veld Pharmaceuticals Partners with Chiesi to Launch Rare Disease Access Program Across Africa
去年
Chiesi's ELFABRIO Shows Promise in Phase 3 Trial for Fabry Disease with Twice-Dose Regimen
10个月前
Chiesi Discontinues COPD Drug Tanimilast After Phase III Trial Failure
去年
EMA Validates Less Frequent Dosing Regimen for Elfabrio in Fabry Disease
去年
Elfabrio Shows Promise in Phase 3 BRIGHT Study for Fabry Disease
3个月前
Chiesi Global Rare Diseases Highlights Advancements in Lipodystrophy Research at ENDO 2026
去年
Chiesi Group and Key2Brain Expand Partnership with Worldwide Licensing Deal for Blood-Brain Barrier-Crossing Therapies
11个月前
PANTHERx Rare Partners with Chiesi as Exclusive Distributor for Oral Acromegaly Treatment MYCAPSSA
去年
Chiesi Farmaceutici's Inhaled PI3Kδ Inhibitor Suggests Target Unsuitability for COPD Management
去年
Elgan Pharma and Chiesi Begin Phase 3 Trial of ELGN-2112 for Intestinal Malabsorption in Preterm Infants
第 1 页,共 491 页
上一页
下一页